BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 10635772)

  • 1. [C3 receptor (CR1, 2, 3, 4)].
    Seya T
    Nihon Rinsho; 1999 Nov; 57 Suppl():50-4. PubMed ID: 10635772
    [No Abstract]   [Full Text] [Related]  

  • 2. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
    Kazatchkine MD; Fearon DT
    Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus.
    Delibrias CC; Mouhoub A; Fischer E; Kazatchkine MD
    Eur J Immunol; 1994 Nov; 24(11):2784-8. PubMed ID: 7957570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
    Fischer E; Appay MD; Cook J; Kazatchkine MD
    J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL.
    Delibrias CC; Fischer E; Bismuth G; Kazatchkine MD
    J Immunol; 1992 Aug; 149(3):768-74. PubMed ID: 1386093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of complement C3 receptors on human astrocytes.
    Gasque P; Chan P; Mauger C; Schouft MT; Singhrao S; Dierich MP; Morgan BP; Fontaine M
    J Immunol; 1996 Mar; 156(6):2247-55. PubMed ID: 8690915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory functions of complement: structural and functional studies of complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21).
    Fearon DT; Klickstein LB; Wong WW; Wilson JG; Moore FD; Weis JJ; Weis JH; Jack RM; Carter RH; Ahearn JA
    Prog Clin Biol Res; 1989; 297():211-20. PubMed ID: 2531419
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface.
    Walport M; Ng YC; Lachmann PJ
    Clin Exp Immunol; 1987 Sep; 69(3):501-7. PubMed ID: 2959411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and signalling functions of C3 receptors on human B cells.
    Frade R
    Semin Immunol; 1990 Mar; 2(2):159-64. PubMed ID: 2151800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.
    Reynes M; Aubert JP; Cohen JH; Audouin J; Tricottet V; Diebold J; Kazatchkine MD
    J Immunol; 1985 Oct; 135(4):2687-94. PubMed ID: 2411809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of complement in host resistance to systemic fungal infection.
    Calderone RA; Linehan L
    Immunol Ser; 1989; 47():225-42. PubMed ID: 2535181
    [No Abstract]   [Full Text] [Related]  

  • 14. Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors.
    Noorchashm H; Moore DJ; Lieu YK; Noorchashm N; Schlachterman A; Song HK; Barker CF; Naji A
    Cell Immunol; 1999 Jul; 195(1):75-9. PubMed ID: 10433799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes.
    Leslie RG; Prodinger WM; Nielsen CH
    Eur J Immunol; 2003 Dec; 33(12):3311-21. PubMed ID: 14635039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
    Molina H; Kinoshita T; Webster CB; Holers VM
    J Immunol; 1994 Jul; 153(2):789-95. PubMed ID: 8021513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte complement C3b receptor (CR1) levels and immune complex-induced manifestations in patients with primary Sjögren's syndrome.
    Thomsen BS; Oxholm P; Nielsen H; Manthorpe R
    Scand J Rheumatol Suppl; 1986; 61():127-30. PubMed ID: 2954207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA; Ng YC; Paccaud JP; Walport MJ
    Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structures.
    Greil R; Gattringer C; Schulz T; Knapp W; Radaskiewicz T; Dierich MP; Huber H
    Clin Exp Immunol; 1986 May; 64(2):423-31. PubMed ID: 2943542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.